Literature DB >> 18279477

Lean body mass normalizes the effect of obesity on renal function.

Sarayut Janmahasatian, Stephen B Duffull, Avry Chagnac, Carl M J Kirkpatrick, Bruce Green.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18279477      PMCID： PMC2485235          DOI： 10.1111/j.1365-2125.2008.03112.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

Review 1.  Measurement of renal function in chronic renal disease.

Authors:  A S Levey
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Glomerular hemodynamics in severe obesity.

Authors:  A Chagnac; T Weinstein; A Korzets; E Ramadan; J Hirsch; U Gafter
Journal:  Am J Physiol Renal Physiol       Date:  2000-05

4.  Quantification of lean bodyweight.

Authors:  Sarayut Janmahasatian; Stephen B Duffull; Susan Ash; Leigh C Ward; Nuala M Byrne; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Glomerular filtration rate in severely overweight normotensive humans.

Authors:  P Anastasio; L Spitali; A Frangiosa; D Molino; D Stellato; E Cirillo; R M Pollastro; L Capodicasa; J Sepe; P Federico; N Gaspare De Santo
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

6.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121
  6 in total
  25 in total

1.  Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.

Authors:  Simone van Kralingen; Jeroen Diepstraten; Mariska Y M Peeters; Vera H M Deneer; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

2.  Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey.

Authors:  Michael A Barras; Carl M J Kirkpatrick; Bruce Green
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

3.  The pharmacokinetics of oxypurinol in people with gout.

Authors:  Sophie L Stocker; Andrew J McLachlan; Radojka M Savic; Carl M Kirkpatrick; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease.

Authors:  James B Wetmore; Robyn A Honea; Eric D Vidoni; Ammar Almehmi; Jeffrey M Burns
Journal:  Nephrol Dial Transplant       Date:  2010-11-23       Impact factor: 5.992

5.  Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass.

Authors:  Luca La Colla; Andrea Albertin; Giorgio La Colla; Andrea Porta; Giorgio Aldegheri; Domenico Di Candia; Fausto Gigli
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

6.  Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events.

Authors:  Michael A Barras; Stephen B Duffull; John J Atherton; Bruce Green
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

7.  A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.

Authors:  Janna K Duong; M Y A M Kroonen; S S Kumar; H L Heerspink; C M Kirkpatrick; G G Graham; K M Williams; R O Day
Journal:  Eur J Clin Pharmacol       Date:  2017-04-28       Impact factor: 2.953

8.  Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.

Authors:  Grégoire Wuerzner; Murielle Bochud; Vittorio Giusti; Michel Burnier
Journal:  Obes Facts       Date:  2011-06-06       Impact factor: 3.942

9.  Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.

Authors:  Yvonne S Lin; Savannah J Kerr; Timothy Randolph; Laura M Shireman; Tauri Senn; Jeannine S McCune
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

10.  Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.

Authors:  Janna K Duong; Shaun S Kumar; Carl M Kirkpatrick; Louise C Greenup; Manit Arora; Toong C Lee; Peter Timmins; Garry G Graham; Timothy J Furlong; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.